Knowledge pico laser machine What is the clinical rationale and protocol for utilizing multimodal laser therapies when managing hypertrophic surgical and traumatic scars? Discover key strategies for optimal scar treatment.
Author avatar

Tech Team · Belislaser

Updated 1 week ago

What is the clinical rationale and protocol for utilizing multimodal laser therapies when managing hypertrophic surgical and traumatic scars? Discover key strategies for optimal scar treatment.


Multimodal laser therapy is justified because hypertrophic scars are not a single problem. Their erythema, abnormal pigmentation, raised contour, collagen density, and possible contracture arise from different biological processes. Vascular lasers such as pulsed dye laser (PDL) address redness and scar microcirculation, while fractional nonablative or ablative lasers create controlled thermal injury that promotes collagen remodeling and improves thickness, elasticity, and texture. The protocol should therefore be staged and individualized according to scar maturity, vascularity, elevation, location, skin type, and tension.

The central principle is to match each laser wavelength and treatment depth to a specific scar feature. In many hypertrophic scars, PDL is used first to reduce vascularity and erythema, followed when appropriate by fractional CO2 or Er:YAG resurfacing to remodel dense collagen and flatten elevated tissue.

Why a Multimodal Approach Is Clinically Rational

Hypertrophic scars contain several treatment targets

Hypertrophic surgical and traumatic scars commonly combine persistent erythema, hyperpigmentation, increased thickness, firmness, and altered texture. A single laser modality rarely addresses all of these features equally well.

The treatment objective is to normalize vascular activity, reduce excessive collagen organization, improve pliability, and restore a more even surface while keeping the tissue response within the original wound boundaries.

Vascular lasers address erythema and microvascular activity

PDL, commonly using a wavelength around 585-595 nm, selectively targets hemoglobin within abnormal superficial vessels. This process, known as selective photothermolysis, can reduce scar redness and may also influence the biological signals that sustain excessive collagen production.

PDL is particularly useful when erythema and vascular prominence are major clinical features. A 585-nm PDL is described as a standard noninvasive option for hypertrophic scars after facial surgery, although treatment response varies with scar age, depth, skin type, and treatment settings.

Fractional lasers remodel raised and firm tissue

Fractional lasers deliver microscopic columns of thermal injury separated by untreated skin. These treatment zones stimulate wound-healing and collagen remodeling while preserving intervening tissue that supports re-epithelialization.

Nonablative fractional lasers produce dermal heating without removing the surface. They may be useful when texture and firmness require remodeling but the scar does not justify tissue ablation.

Fractional ablative CO2 or Er:YAG lasers remove microscopic columns of tissue and create deeper coagulation or thermal stimulation. They are generally considered when the scar is substantially raised, dense, stiff, or resistant to less invasive treatment.

Combining mechanisms improves customization

The combination allows clinicians to treat the scar’s color and architecture separately. PDL can reduce vascularity, while fractional treatment addresses collagen density, elevation, and surface irregularity.

This is more adaptable than applying the same treatment to every scar. A thin, red, early hypertrophic scar may need vascular treatment and conservative remodeling, whereas an older, thick, firm scar may require deeper fractional treatment or additional interventions.

A Practical Clinical Protocol

Begin with assessment and classification

Before treatment, document:

  • Scar location, dimensions, age, and cause
  • Erythema, pigmentation, thickness, firmness, and surface texture
  • Symptoms such as pain, itch, or sensitivity
  • Pliability, contracture, and functional limitation
  • Whether the scar remains within the original wound margins
  • Fitzpatrick skin type and risk of post-inflammatory hyperpigmentation
  • Previous treatment, including corticosteroid injections, surgery, cryotherapy, or laser therapy

A scar that extends beyond the original wound margins is more consistent with a keloid, not a hypertrophic scar. Mature, dense keloids often respond poorly to laser monotherapy and require a broader prevention and recurrence strategy.

Confirm that the wound is ready

Laser treatment should be performed only after the surgical or traumatic wound has adequately healed and there is no active infection, dehiscence, drainage, or uncontrolled inflammation.

The clinician should also review factors that can increase adverse effects, including recent isotretinoin exposure, photosensitizing medication, impaired healing, uncontrolled inflammatory skin disease, and a history of abnormal wound healing. For patients who have taken oral isotretinoin, the supplementary reference recommends delaying aggressive resurfacing for at least six months; this interval should be confirmed against current specialist guidance and the patient’s treatment history.

Treat prominent vascularity first

When redness is a major feature, PDL is commonly used as the initial laser modality. Treatment parameters should be selected by an experienced clinician according to scar thickness, vessel appearance, location, skin type, and the device’s spot size, pulse duration, and cooling system.

A staged course is usually more appropriate than a single aggressive session. The scar is reassessed after healing, with further vascular treatments considered if erythema remains prominent.

Address pigmentation conservatively

Hyperpigmentation requires particular caution because laser-induced inflammation can worsen pigmentary change, especially in Fitzpatrick skin types IV-VI.

The clinician should consider conservative test treatment, appropriate cooling, careful energy selection, and strict photoprotection. Pigment management should not be pursued with settings that create unnecessary inflammation, particularly when vascular or textural treatment can be staged separately.

Add fractional remodeling for elevation and firmness

Once vascular activity is controlled, fractional treatment can target thickness, stiffness, and surface irregularity. Fractional CO2 or Er:YAG treatment may be selected when deeper collagen remodeling or controlled tissue ablation is required.

Energy depth and density should be adjusted to the scar’s thickness, maturity, anatomical site, and the presence of contracture or tension. Off-face scars often require different settings and healing expectations from facial scars, and deeper treatment is not automatically better.

Sequence procedures from deeper to shallower

When several procedures are performed during the same session, the general sequence is:

  1. Deep mechanical or subdermal procedures, such as subcision when clinically indicated
  2. Fractional ablative laser treatment, such as CO2 or Er:YAG
  3. More superficial energy-based or adjunctive procedures, when appropriate
  4. Mechanical procedures that create micro-bleeding, such as microneedling

Energy-based procedures should generally precede bleeding-producing mechanical procedures. Blood pooling can act as an unwanted chromophore and interfere with more uniform optical energy absorption.

The exact sequence depends on the devices and procedures being combined. A clinician should avoid combining modalities merely to increase intensity; each step should have a defined target and recovery plan.

Integrate nonlaser treatments when needed

Laser therapy may be combined with other scar treatments when elevation, recurrence risk, or contracture exceeds what laser treatment can reasonably address.

Potential adjuncts include intralesional corticosteroid therapy, silicone gel or sheets, hydrogels, cryotherapy, surgical management, and low-level light therapy. For selected scars, intralesional steroid treatment combined with PDL may provide greater reduction than PDL alone.

Contracture or significant mechanical tension may require surgical release or other specialist treatment. Laser remodeling cannot reliably correct a scar whose primary problem is unresolved tension.

Managing Treatment Intensity and Follow-Up

Use staged reassessment

The scar should be evaluated after each treatment cycle for changes in redness, thickness, pliability, pigment, symptoms, and function.

Follow-up should determine whether the next session should target vascularity, collagen remodeling, pigmentation, or a nonlaser problem such as tension or recurrence. This is more clinically defensible than committing to identical settings at fixed intervals.

Expect gradual remodeling

Fractional treatment produces controlled injury, not immediate scar replacement. Improvement in firmness, elevation, and elasticity develops during subsequent remodeling and may require multiple sessions.

Patients should receive realistic expectations about redness, swelling, crusting, pigment alteration, and the time required for scar maturation. The endpoint is meaningful improvement in appearance, symptoms, and function, not necessarily complete elimination of the scar.

Monitor for adverse effects

PDL commonly causes purpura, which typically resolves within 7-10 days according to the supplementary reference. Other possible effects include prolonged erythema, blistering, crusting, infection, pigmentary alteration, and textural change.

Darker skin types require particular caution because of increased risk of post-laser hyperpigmentation. Test spots, conservative settings, cooling, and rigorous sun protection can help reduce risk, but they do not eliminate it.

Understanding the Trade-offs

More aggressive treatment can increase inflammation

Ablative fractional lasers may provide stronger remodeling for dense scars, but they also create greater tissue injury, downtime, and risk of pigmentary or textural complications.

The appropriate depth is the minimum effective depth for the scar’s clinical problem. Increasing energy without addressing the correct target can produce more inflammation without proportional benefit.

Laser monotherapy may be inadequate

Very firm scars, recurrent keloids, scars with contracture, and lesions driven by ongoing tension may not respond sufficiently to laser alone.

Keloids are especially different from hypertrophic scars because they extend beyond the original wound margins. Early, softer keloids may respond to PDL, but mature dense keloids generally require multimodal management and recurrence prevention.

PDL is not a universal remodeling treatment

PDL is well suited to vascularity and erythema, but it does not replace fractional treatment when the dominant problem is dense elevation or stiffness.

Conversely, fractional CO2 treatment should not be selected solely because a scar is raised if active vascularity, pigmentation risk, or poor healing makes a vascular-first or more conservative strategy safer.

Protocols cannot be reduced to one setting

The appropriate wavelength, fluence, pulse duration, density, treatment depth, cooling, and interval depend on the device and the patient.

Scar thickness, age, facial versus nonfacial location, skin type, vascularity, and contracture all change the risk-benefit balance. A protocol copied from another anatomical site or device may be inappropriate.

Making the Right Choice for Your Goal

The treatment plan should be built around the dominant clinical problem and revised as the scar changes.

  • If your primary focus is reducing redness: Begin with a vascular laser such as PDL, using conservative, clinician-selected settings and reassessing erythema after healing.
  • If your primary focus is flattening a thick or firm scar: Consider staged fractional remodeling, with fractional CO2 or Er:YAG treatment selected according to scar depth, maturity, and skin type.
  • If your primary focus is treating pigmentation safely: Prioritize conservative energy selection, test areas, cooling, and photoprotection, particularly for Fitzpatrick IV-VI skin.
  • If your primary focus is improving pliability or contracture: Evaluate tension and mechanical restriction first, because laser treatment may need to be combined with release, injection, or other specialist therapy.
  • If your primary focus is preventing recurrence in a keloid-prone patient: Use a multimodal plan that may include vascular treatment, corticosteroid or other adjunctive therapy, silicone-based care, and close follow-up rather than laser monotherapy.

The most reliable protocol is a staged, target-specific plan that treats vascularity, pigmentation, and collagen architecture according to the scar’s biology and the patient’s healing risk.

Summary Table:

Target Feature Laser Modality Mechanism Key Considerations
Erythema/Vascularity Pulsed Dye Laser (PDL) Selective photothermolysis of hemoglobin Use for redness; purpura resolves in 7-10 days
Thickness/Firmness Fractional Ablative (CO2/Er:YAG) Controlled thermal injury induces collagen remodeling Adjust depth to scar thickness; higher risk of side effects
Texture/Surface Fractional Non-ablative Dermal heating promotes remodeling with less downtime For mild elevation and texture improvements
Pigmentation Conservative laser settings with cooling Avoid excessive inflammation; use test spots High risk in skin types IV-VI; strict photoprotection

Elevate your practice with BELIS's advanced laser systems, including PDL, fractional CO2, and Nd:YAG, designed for clinics and premium salons. Our multimodal solutions empower you to address erythema, texture, and thickness with precision. Partner with us for OEM/ODM support, certifications, and reliable supply. Contact our experts today to customize your scar management protocols and expand your treatment offerings.

Related Products

People Also Ask

Related Products

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin resurfacing, scar removal & anti-aging. 40W/60W power, adjustable modes & minimal downtime. FDA-approved for safe treatments.

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin rejuvenation, scar removal, and gynecological treatments. Dual-mode precision with customizable settings. Learn more now!

Multifunctional Laser Hair Growth Machine Device for Hair Growth

Multifunctional Laser Hair Growth Machine Device for Hair Growth

BELIS Laser Hair Growth Machine: 650nm cold laser therapy for hair regrowth, safe & effective for clinics. Non-invasive, FDA-approved, visible results.

Multifunctional Laser Hair Growth Machine Device for Hair Growth

Multifunctional Laser Hair Growth Machine Device for Hair Growth

BELIS Multifunctional Laser Hair Growth Machine: Stimulate hair regrowth, scalp health & skin rejuvenation with 650nm diode laser. Safe, pain-free, clinically proven.

12D HIFU Machine Device for Facial HIFU Treatment

12D HIFU Machine Device for Facial HIFU Treatment

12D HIFU machine for non-invasive skin tightening & body contouring. Reduces wrinkles, lifts sagging skin, targets fat. Safe, no downtime. 2-year warranty.

Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments

Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments

Versatile 7D HIFU system designed for professional HIFU clinics, offering face and vaginal treatments, body sculpting, and skin tightening. Features micro and macro focused ultrasound, 9 interchangeable cartridges with up to 20,000 shots each, and a large intuitive touchscreen.


Leave Your Message